Physician profile
Ghai C Lu
NPI 1588763429
$3,014.20
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,399 · 2020: $691 · 2021: $521 · 2022: $404.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $337.97 | 2019-2022 | |
| Glaxosmithkline, LLC. | $322.71 | 2019-2022 | |
| Amgen INC. | $305.85 | 2019-2022 | |
| Novo Nordisk INC | $220.14 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $217.87 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $197.40 | 2019-2022 | |
| Abbvie INC. | $172.71 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $160.43 | 2019-2022 | |
| Amarin Pharma, INC. | $158.28 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $152.84 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $140.80 | 2019-2022 | |
| Lilly USA, LLC | $126.22 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $68.72 | 2019-2021 | |
| Allergan, INC. | $61.78 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.11 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $40.35 | 2021-2022 | |
| Pfizer INC. | $39.53 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $33.79 | 2019 | |
| Sanofi Pasteur INC. | $27.21 | 2020 | |
| Avanir Pharmaceuticals, INC. | $22.72 | 2019 | |
| Medtronic Minimed, INC. | $20.45 | 2020 | |
| Abbott Laboratories | $19.98 | 2022 | |
| Eisai INC. | $19.14 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $18.13 | 2022 | |
| Astellas Pharma US INC | $17.40 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.80 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.92 | 2019 | |
| Shire North American Group INC | $13.42 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.37 | 2019 | |
| Circassia INC. | $11.16 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ghai Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.